-
Benicar Cardiovascular-Related Deaths: FDA Safety Review Which Started In June 2010 Is Still Ongoing In August 2013
When Will Daiichi Sankyo And FDA Report On Additional Studies And Analyses Of Clinical Studies About Cardiovascular Mortality Increased Risks Of Benicar (Posted by Tom Lamb at DrugInjuryWatch.com) In June 2010 the FDA issued…
-
Blood Pressure Drug Benicar Causes Serious Intestinal Side Effects Such As Chronic And Severe Diarrhea Months Or Years After Starting Drug
Olmesartan-associated Sprue-like Enteropathy FDA Warning Also Applies To Benicar HCT, Azor, And Tribenzor From Drug Company Daiichi Sankyo (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA has found clear evidence of an association between…
-
Levaquin / Cipro / Avelox: Small But Significant Increased Risk Of Acute Kidney Injury Among Men According To Recent Study
In Addition, A Significant Drug-Drug Interaction Between The Concomitant Use Of Fluoroquinolones And Renin–Angiotensin-System Blockers (Posted by Tom Lamb at DrugInjuryWatch.com) An article published by the Canadian Medical Association during June 2013 in its…
-
Levaquin / Cipro / Avelox: Retinal Detachments Are Visual Side Effects Of Oral Fluoroquinolones Antibiotics
Health Canada Suggests That Low Level Or Under-Reporting For These Adverse Reactions Involving Eyesight Is Due To The Limited Information Available (Posted by Tom Lamb at DrugInjuryWatch.com) Back in April 2012 we posted this…
-
Depacon / Depakene / Depakote: 400% Increased Risk Of Birth Defects Compared To Other Anti-Seizure Medications Used By Mothers With Epilepsy
May 2013 Revised Depakote Drug Label Includes "Black-Box" And Warnings About These Congenital Malformations As Well As Decreased IQ Scores In Children (Posted by Tom Lamb at DrugInjuryWatch.com) As indicated below, in May 2013…
-
July 2013 Update: New FDA Action To Be Taken In Or About September On Issue Of Drug Label Revisions By Generic Manufacturers
Allowing Supplemental Applications For Proposed Labeling Changes Might End Federal Preemption Shield From Legal Liability That Came With Mensing Ruling (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: The FDA’s long-awaited proposed rule on…